Epilepsy Research
Volume 23, Issue 2 , Pages 139-148 , March 1996

Cost of refractory epilepsy in adults in the USA

  • Miranda I. Murray

      Affiliations

    • Corresponding Author InformationCorresponding author.
    • Battelle, Centers for Public Health Research and Evaluation, 2101 Wilson Boulevard, Suite 800, Arlington, VA 22201, USA
    • ,
  • Michael T. Halpern

      Affiliations

    • Battelle, Centers for Public Health Research and Evaluation, 2101 Wilson Boulevard, Suite 800, Arlington, VA 22201, USA
    • ,
  • Ilo E. Leppik

      Affiliations

    • MINCEP Epilepsy Care and Department of Neurology and Pharmacy, University of Minnesota, 5775 Wayzata Boulevard, Minneapolis, MN 55416, USA

Received 1 May 1995 ,Accepted 15 September 1995.

References 

  1. Begley CE, Annegers JF, Lairson DR, Reynolds TC, Hauser WA. The cost of epilepsy in the United States: A model based on incidence and prognosis. Epilepsia. 1994;35:1230–1243
  2. Benichou C, Dannanan , Flahault A. Causality assessment of adverse reactions to drugs. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J. Clin. Epidemiol. 1993;46:1331–1336
  3. Cascino GD. Intractable partial epilepsy: Evaluation and treatment. In: 2nd ed.. Mayo Clin. Proc. 65:1990;p. 1578–1586
  4. Department of Health Education and Welfare, National Institutes of Health . Plan for Nationwide Action on Epilepsy. In: 2nd ed.. DHEW Publication No. (NIH) 79-1115. 1978; Washington
  5. Engel J. Update on surgical treatment of the epilepsies. In: Summary of the Second International Palm Desert Conference on the Surgical Treatment of the Epilepsies. 1992. 2nd ed.. Neurology. 43:1993;p. 1612–1617
  6. Expert Panel, 1994.
  7. Fink A, Kosecoff J, Chassin M, et al.  Consensus methods: Characteristics and guidelines for use. Am. J. Public Health. 1984;74:979–983
  8. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia. 1993;34:453–468
  9. Hauser WA, Hersdorffer DC. Incidence and prevalence. In:  Hauser WA,  Hersdorffer DC editor. Epilepsy: Frequency, Causes and Consequences. New York: Demos Press; 1990;p. 1–49
  10. Hauser A. Postscript: How should outcome be determined and reported?. In:  Engel J editors. Surgical Treatment of the Epilepsies. New York: Raven Press; 1987;p. 573–579
  11. Luce BR, Elixhauser A. In:  Culyer AJ editors. Standards for Socioeconomic Evaluation of Health Care Products and Services. Berlin: Springer-Verlag; 1990;
  12. Mazzuca SA, Cohen SJ. Securing patient management problems: External validity of expert consensus. Eval. Health Prof. 1982;5022:210–217
  13. Navarro RP, Ashraf T. Cost analysis of carbamazepine, phenytoin, and valproate for use in complex partial seizures. Pharmacoeconomics. 1993;113–118
  14. National Center for Health Statistics . National Health Interview Survey. 1987;
  15. NIH Consensus Panel . Consensus conferences on surgery for epilepsy. J. Am. Med. Assoc. 1990;264:729–733
  16. Pashko S, McCord A, Sena MM. The cost of epilepsy and seizures in a cohort of Pennsylvania medicaid patients. Pharmacoeconomics. 1993;79–84
  17. Sanmarco ME, Brooks SH, Balkenhorn DH. Reproducibility of a consensus panel in the interpretation of coronary angiograms. Am. Heart J. 1978;96:430–437
  18. Silfvenius H. Economic costs of epilepsy—treatment benefits. Acta Neurol. Scand. 1988;117:136–154
  19. Sniezek JA. A comparison group of techniques for judgmental forecasting by groups with common information. Group Organization Stud. 1990;15:5–19
  20. U.S. Bureau of the Census . Census Statistics. 1992;
  21. U.S. Department of Labor, Department of Labor Statistics, 1992.

PII: 0920-1211(95)00090-9

Epilepsy Research
Volume 23, Issue 2 , Pages 139-148 , March 1996

Article Tools